Jasen Gundersen never considered a career in business when he entered medical school nearly three decades ago to become a rural primary care doctor.
Pfizer axes sickle cell, beta thalassemia deal with Syros
Pfizer terminated a deal that Syros Pharmaceuticals made with Global Blood Therapeutics to develop treatments for beta thalassemia and sickle cell disease. Pfizer acquired GBT